Immune profiling of a patient with relapsed HIV-Related and EBV-positive diffuse large B-Cell lymphoma treated with pembrolizumab

Leuk Lymphoma. 2022 May;63(5):1256-1260. doi: 10.1080/10428194.2021.2012571. Epub 2021 Dec 16.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Epstein-Barr Virus Infections* / complications
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Herpesvirus 4, Human
  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / diagnosis
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy
  • Lymphoma, Large B-Cell, Diffuse* / pathology

Substances

  • Antibodies, Monoclonal, Humanized
  • pembrolizumab